Department of Gastroenterology and Hepatology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands; Department of Surgery, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
Department of Surgery, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
Eur J Surg Oncol. 2018 Sep;44(9):1361-1370. doi: 10.1016/j.ejso.2018.06.001. Epub 2018 Jun 8.
The efficacy of auditing is still a subject of debate and concerns exist whether auditing promotes risk averse behaviour of physicians. This study evaluates the achievements made in colorectal cancer surgery since the start of a national clinical audit and assesses potential signs of risk averse behaviour.
Data were extracted from the Dutch ColoRectal Audit (2009-2016). Trends in outcomes were evaluated by uni and multivariable analyses. Patients were stratified according to operative risks and changes in outcomes were expressed as absolute (ARR) and relative risk reduction (RRR). To assess signs of risk averse behaviour, trends in stoma construction in rectal cancer were analysed.
Postoperative mortality decreased from 3.4% to 1.8% in colon cancer and from 2.3% to 1% in rectal cancer. Surgical and non-surgical complications increased, but with less reintervention. For colon cancer, the high-risk elderly patients had the largest ARR for complicated postoperative course (6.4%) and mortality (5.9%). The proportion of patients receiving a diverting stoma or end colostomy after a (L)AR decreased 11% and 7%, respectively. In low rectal cancer, patients increasingly received a non-diverted primary anastomosis (5.4% in 2011 and 14.4% in 2016).
No signs of risk averse behaviour was found since the start of the audit. Especially the high-risk elderly patients seem to have benefitted from improvements made in colon cancer treatment in the past 8 years. For rectal cancer, trends towards the construction of more primary anastomoses are seen. Future quality improvement measures should focus on reducing surgical and non-surgical complications.
审核的效果仍然是一个有争议的话题,人们担心审核是否会促使医生采取规避风险的行为。本研究评估了自全国临床审核开始以来结直肠癌手术所取得的成就,并评估了潜在的规避风险行为的迹象。
从荷兰结直肠审核(2009-2016 年)中提取数据。通过单变量和多变量分析评估结果趋势。根据手术风险对患者进行分层,并表示手术结果的绝对(ARR)和相对风险降低(RRR)变化。为了评估规避风险行为的迹象,分析直肠癌造口术的变化趋势。
结肠癌术后死亡率从 3.4%降至 1.8%,直肠癌术后死亡率从 2.3%降至 1%。手术和非手术并发症增加,但再干预减少。对于结肠癌,高危老年患者术后并发症(6.4%)和死亡率(5.9%)的 ARR 最大。接受(L)AR 后预防性造口术或末端结肠造口术的患者比例分别下降了 11%和 7%。在低位直肠癌中,越来越多的患者接受非预防性吻合术(2011 年为 5.4%,2016 年为 14.4%)。
自审核开始以来,没有发现规避风险行为的迹象。特别是高危老年患者似乎从过去 8 年中结肠癌治疗的改善中受益。对于直肠癌,更多的一期吻合术的趋势明显。未来的质量改进措施应重点减少手术和非手术并发症。